Discuss Your Next Design Project
Company / News

Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)

post_banner

Guidance for Industry and Food and Drug Administration Staff

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19 for the duration of the COVID-19 public health emergency.

Download Whitepaper

download whitepaper

TELL US ABOUT YOUR NEXT DESIGN PROJECT

Do you have a question about our services, pricing, samples, resources, or anything else?

Contact Us Now

Related News

Cybersecurity Experts Hail New IoT law | Voler Systems

Cybersecurity experts are keenly aware of ongoing security issues that come with...

Read More

Our Partner | Renesas | Voler Systems

Renesas is a leading supplier of microprocessors and a wide range of other chips. Voler...

Read More

Webinar: Wearables & Remote Monitoring For Elderly Patients

Monday, July 22nd at 5:00pm PDT Tuesday, July 23 at 9:00am JST

Read More

Interested in Learning More? Contact Us Today!